Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine for Sedation in Regional Block
NCT05447507Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Number of rescue sedative doses administered. Started Jul 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05447507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447507.